ENTITY
Bayer

Bayer (BAYN GR)

70
Analysis
Health Care • Germany
Bayer AG produces and markets healthcare and agricultural products. The Company manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
more
bullish•Monsanto Co
•14 Aug 2017 16:39

Monsanto / Bayer: Vertical and Conglomerate Antitrust Issues

To date, the gating item as it relates to Monsanto / Bayer deal timing has been the formal antitrust filing with European Competition Commission...

Share
bullish•Monsanto Co
•06 Aug 2017 20:17

Monsanto/Bayer CFIUS Review Following Normal Course

The voluntary joint filing by Bayer and Monsanto to the Committee on Foreign Investment in the United States continues to undergo a lengthy review....

Logo
295 Views
Share
bullish•Monsanto Co
•30 Jul 2017 23:52

CADE to Decide on Monsanto/Bayer by Year-End or Early 2018

Brazilian regulator CADE is not expected to issue a decision on the ongoing merger between German biotech giant Bayer and GMO-focused peer Monsanto...

Logo
225 Views
Share
bullish•Monsanto Co
•18 Jun 2017 20:00

Bayer Acquisition of Monsanto Likely to Extend into 2018, Sources Say

Industry sources believe that the Bayer acquisition of Monsanto will be delayed into 2018.  Bayer has not yet filed with Brussels authorities for...

Logo
338 Views
Share
bullish•Monsanto Co
•28 Apr 2017 16:09

Monsanto /​ Bayer: Horizontal Antitrust Issues

Sentiment in Monsanto continues its positive trend. After Berkshire Hathaway disclosed a 1.8% stake in February, and Monsanto and Bayer held a...

Share
x